We use cookies to ensure that we give you the best experience on our website. When you use our platform without an account you need to read and accept the Terms of Service, Data Policy and Disclaimer(s).

Accept Deny Options

v. 0.2.2

Palmy Investing

Home
Portfolios
Watchlists
Screener
Stocks My Comparisons
Focus (Quotes)
Articles
Meta Industries
Sectors
Macro
Forex
Controlling My Account Log Out

Resources

Pricing Disclaimer Contact TOS Imprint

Getting Started

Search

Suggestions
Berkshire Hathaway Profile, Qualitative, Financials ... Overview
Royal Bank Of Canada Valuation Models & History Financials
Alphabet Inc. - Competitors SNAP, TWLO, PINS, META ... Comp.
Amazon.com, Inc. Risks/AI NLP Analyzed Risk Factors, AI Arguments
Apple Inc. vs. Peers & Industry Benchmarks Benchmarks Industry
Peter Lynch Screener Strategy

Where Can I Read About All The Dashboard Features?

Add MRK to watchlist(s)

You Should Create a Watchlist In The First Place.

News

Theses · Events · Sentiments

Sentiments

24-09-09 -33.40%

Summit Therapeutics said its Ivonescimab treatment reduced the risk of disease progression or death by 49% compared with the market …

Merck & Co., Inc.

Other Listings:

EURONEXT:MRK.PA

All Together

Profile An in-depth corporate profile of MRK
Qualitative Arguments, Risk Factors (SEC), FAQ ...
Income Statements Up to 40Yrs of financial data
Balance Sheets Up to 40Yrs of financial data
Cashflow Statements Up to 40Yrs of financial data
Financial Ratios Up to 40Yrs of financial data
Fundamental Analysis (FA) Naive, Benchmarked, DuPont
Dividends Over Decades, Growth, Ratios
News Sentiments, Events, Theses
Documents Filing Reader, SEC, Links

ISIN: US58933Y1055 CUSIP: 58933Y105

Share Your Research

Share this link via

Or copy link

Terminal Options

Compotion

Please visit the 'My Terminals' page to utilize all 'Terminal Options' ...

Save Terminal

As Terminal As Watchlist

Search Engine

Equities

ETFs

Indices

More or other configuration? Head Over To Account Settings